Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

A case of equine cryptorchidism with undetectable serum anti-Müllerian hormone.

Murase H, Ochi A, Tozaki T, Kakoi H, Munkhtuul T, Kurimoto S, Sato F, Hada T.

J Vet Med Sci. 2019 Dec 26. doi: 10.1292/jvms.18-0057. [Epub ahead of print]

2.

Reduction in maxillary complete denture deformation using framework material made by computer-aided design and manufacturing systems.

Hada T, Suzuki T, Minakuchi S, Takahashi H.

J Mech Behav Biomed Mater. 2019 Nov 14;103:103514. doi: 10.1016/j.jmbbm.2019.103514. [Epub ahead of print]

PMID:
31778908
3.

The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system.

Yabe T, Muramatsu T, Tsukahara R, Nakano M, Takimura H, Kawano M, Hada T, Ikeda T.

Heart Vessels. 2019 Sep 14. doi: 10.1007/s00380-019-01502-1. [Epub ahead of print]

PMID:
31522247
4.

Simulation platforms to assess laparoscopic suturing skills: a scoping review.

Bilgic E, Alyafi M, Hada T, Landry T, Fried GM, Vassiliou MC.

Surg Endosc. 2019 Sep;33(9):2742-2762. doi: 10.1007/s00464-019-06821-y. Epub 2019 May 14.

PMID:
31089881
5.

Effective Therapy Using a Liposomal siRNA that Targets the Tumor Vasculature in a Model Murine Breast Cancer with Lung Metastasis.

Sakurai Y, Hada T, Kato A, Hagino Y, Mizumura W, Harashima H.

Mol Ther Oncolytics. 2018 Oct 30;11:102-108. doi: 10.1016/j.omto.2018.10.004. eCollection 2018 Dec 21.

6.

A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.

Takimura H, Hada T, Kawano M, Yabe T, Takimura Y, Nishio S, Nakano M, Tsukahara R, Muramatsu T.

PLoS One. 2018 Nov 14;13(11):e0207481. doi: 10.1371/journal.pone.0207481. eCollection 2018.

7.

Changes of lying behavior in Thoroughbred foals influenced by age, pasturing time, and weather conditions.

Murase H, Matsui A, Endo Y, Sato F, Hada T.

J Equine Sci. 2018 Sep;29(3):61-66. doi: 10.1294/jes.29.61. Epub 2018 Sep 19.

8.

First-in-Man Percutaneous Coronary Intervention Using Instantaneous Wave-Free Ratio Roadmap Functionality With Instantaneous Wave-Free Ratio Scout Pullback.

Yabe T, Muramatsu T, Tsukahara R, Nakano M, Nishio S, Takimura Y, Takimura H, Kawano M, Hada T.

JACC Cardiovasc Interv. 2018 Aug 13;11(15):e119-e120. doi: 10.1016/j.jcin.2018.05.046. Epub 2018 Jul 18. No abstract available.

9.

Diffusion Tensor Imaging Evaluation of Neural Network Development in Patients Undergoing Therapeutic Repetitive Transcranial Magnetic Stimulation following Stroke.

Yamada N, Ueda R, Kakuda W, Momosaki R, Kondo T, Hada T, Sasaki N, Hara T, Senoo A, Abo M.

Neural Plast. 2018 Mar 13;2018:3901016. doi: 10.1155/2018/3901016. eCollection 2018.

10.

Cre-Mediated Transgene Integration in Chinese Hamster Ovary Cells Using Minicircle DNA Vectors.

Wang X, Kawabe Y, Hada T, Ito A, Kamihira M.

Biotechnol J. 2018 Jul;13(7):e1800063. doi: 10.1002/biot.201800063. Epub 2018 May 9.

PMID:
29701326
11.

Impact of orthotic therapy for improving activities of daily living in individuals with spinal cord injury: a retrospective cohort study.

Hada T, Momosaki R, Abo M.

Spinal Cord. 2018 Aug;56(8):790-795. doi: 10.1038/s41393-018-0088-9. Epub 2018 Mar 7.

PMID:
29515213
12.

Efficacy of a Self-timed Trial of Laparoscopic Surgical Training Using a Dry Box.

Chikazawa K, Kanao H, Hada T, Netsu S, Kuwata T, Konno R.

Eplasty. 2018 Feb 8;18:e8. eCollection 2018.

13.

Retroperitoneoscopic Para-Aortic Lymphadenectomy with High-Level Vena Cava Bifurcation.

Kanno K, Andou M, Yanai S, Shirane A, Nakajima S, Ebisawa K, Hada T, Ota Y.

J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):761-762. doi: 10.1016/j.jmig.2017.11.007. Epub 2017 Nov 15. No abstract available.

PMID:
29155006
14.

A Retrospective Study of the Effects of Oncology Pharmacist Participation in Treatment on Therapeutic Outcomes and Medical Costs.

Imamura M, Ogawa D, Takatori T, Yamaguchi M, Takata T, Hada T, Ota Y, Uehara T.

Biol Pharm Bull. 2017;40(11):1956-1962. doi: 10.1248/bpb.b17-00501.

15.

Effect of Myostatin SNP on muscle fiber properties in male Thoroughbred horses during training period.

Miyata H, Itoh R, Sato F, Takebe N, Hada T, Tozaki T.

J Physiol Sci. 2018 Sep;68(5):639-646. doi: 10.1007/s12576-017-0575-3. Epub 2017 Oct 20.

PMID:
29058242
16.

Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations.

Kadhum WR, Hada T, Hijikuro I, Todo H, Sugibayashi K.

J Oleo Sci. 2017;66(9):939-950. doi: 10.5650/jos.ess17032.

17.

Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.

Sakurai Y, Mizumura W, Murata M, Hada T, Yamamoto S, Ito K, Iwasaki K, Katoh T, Goto Y, Takagi A, Kohara M, Suga H, Harashima H.

Mol Pharm. 2017 Oct 2;14(10):3290-3298. doi: 10.1021/acs.molpharmaceut.7b00362. Epub 2017 Aug 25.

PMID:
28789523
18.

Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.

Yamanaka A, Hada T, Matsumoto T, Kanno K, Shirane A, Yanai S, Nakajima S, Ebisawa K, Ota Y, Andou M.

Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:51-55. doi: 10.1016/j.ejogrb.2017.07.014. Epub 2017 Jul 11.

PMID:
28728071
19.

Aborted fetal sizes of Thoroughbred horses in Hidaka, Japan, between 2005 and 2015.

Murase H, Miyazawa M, Harada T, Ozawa M, Sato F, Hada T.

J Equine Sci. 2017;28(2):47-53. doi: 10.1294/jes.28.47. Epub 2017 Jul 6.

20.

Laparoscopic Ureteral Reimplantation for Obstructive Megaureter with Deeply Infiltrating Endometriosis.

Kanno K, Andou M, Oyama K, Yanai S, Shirane A, Nakajima S, Ebisawa K, Hada T, Ota Y.

J Minim Invasive Gynecol. 2018 Mar - Apr;25(3):372-373. doi: 10.1016/j.jmig.2017.06.027. Epub 2017 Jul 5. No abstract available.

PMID:
28688891
21.

Accumulative scFv-Fc antibody gene integration into the hprt chromosomal locus of Chinese hamster ovary cells.

Wang X, Kawabe Y, Kato R, Hada T, Ito A, Yamana Y, Kondo M, Kamihira M.

J Biosci Bioeng. 2017 Nov;124(5):583-590. doi: 10.1016/j.jbiosc.2017.05.017. Epub 2017 Jun 26.

PMID:
28662917
22.

Total Laparoscopic Treatment With Cystotomy for Intramural Bladder Leiomyoma.

Kanno K, Andou M, Yanai S, Shirane A, Nakajima S, Ebisawa K, Hada T, Ota Y.

J Minim Invasive Gynecol. 2018 Jan;25(1):14-15. doi: 10.1016/j.jmig.2017.03.018. Epub 2017 Mar 31. No abstract available.

PMID:
28373126
23.

Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles.

Yamamoto S, Kato A, Sakurai Y, Hada T, Harashima H.

J Control Release. 2017 Apr 10;251:1-10. doi: 10.1016/j.jconrel.2017.02.010. Epub 2017 Feb 10.

24.

Scalable preparation of poly(ethylene glycol)-grafted siRNA-loaded lipid nanoparticles using a commercially available fluidic device and tangential flow filtration.

Sakurai Y, Hada T, Harashima H.

J Biomater Sci Polym Ed. 2017 Jul - Aug;28(10-12):1086-1096. doi: 10.1080/09205063.2017.1291297. Epub 2017 Feb 10.

25.

Quantitative evaluation of cervical cord compression by computed tomographic myelography in Thoroughbred foals.

Yamada K, Sato F, Hada T, Horiuchi N, Ikeda H, Nishihara K, Sasaki N, Kobayashi Y, Nambo Y.

J Equine Sci. 2016;27(4):143-148. Epub 2016 Dec 15.

26.

Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles.

Sakurai Y, Hada T, Yamamoto S, Kato A, Mizumura W, Harashima H.

Mol Ther. 2016 Dec;24(12):2090-2099. doi: 10.1038/mt.2016.178. Epub 2016 Sep 16.

27.

Aluminum potassium sulfate and tannic acid sclerotherapy for Goligher Grades II and III hemorrhoids: Results from a multicenter study.

Miyamoto H, Hada T, Ishiyama G, Ono Y, Watanabe H.

World J Hepatol. 2016 Jul 18;8(20):844-9. doi: 10.4254/wjh.v8.i20.844.

28.

A clinical case of equine fungal placentitis with reference to hormone profiles and ultrasonography.

Murase H, Niwa H, Katayama Y, Sato F, Hada T, Nambo Y.

J Equine Sci. 2015;26(4):129-33. doi: 10.1294/jes.26.129. Epub 2016 Feb 3.

29.

Preparation of a Cyclic RGD: Modified Liposomal SiRNA Formulation for Use in Active Targeting to Tumor and Tumor Endothelial Cells.

Sakurai Y, Hada T, Harashima H.

Methods Mol Biol. 2016;1364:63-9. doi: 10.1007/978-1-4939-3112-5_6.

PMID:
26472442
30.
31.

Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes.

Sakurai Y, Matsuda T, Hada T, Harashima H.

Biol Pharm Bull. 2015;38(8):1185-91. doi: 10.1248/bpb.b15-00138.

32.

Total laparoscopic nerve-sparing radical parametrectomy for occult early-stage cervical cancer: surgical technique and postoperative bladder function.

Kanao H, Fujiwara K, Ebisawa K, Hada T, Ota Y, Andou M.

Gynecol Obstet Invest. 2015;80(2):128-33. doi: 10.1159/000381545. Epub 2015 Apr 28.

PMID:
25924724
33.

Local excision of rectal schwannoma using transanal endoscopic microsurgery: A case report.

Suzuki T, Suwa K, Hada T, Okamoto T, Fujita T, Yanaga K.

Int J Surg Case Rep. 2014;5(12):1193-6. doi: 10.1016/j.ijscr.2014.11.020. Epub 2014 Nov 11.

34.

Various types of total laparoscopic nerve-sparing radical hysterectomies and their effects on bladder function.

Kanao H, Fujiwara K, Ebisawa K, Hada T, Ota Y, Andou M.

J Gynecol Oncol. 2014 Jul;25(3):198-205. doi: 10.3802/jgo.2014.25.3.198. Epub 2014 Jul 3.

35.

Low-energy extracorporeal shock wave therapy improves microcirculation blood flow of ischemic limbs in patients with peripheral arterial disease: pilot study.

Tara S, Miyamoto M, Takagi G, Kirinoki-Ichikawa S, Tezuka A, Hada T, Takagi I.

J Nippon Med Sch. 2014;81(1):19-27.

36.

Therapeutic vascular angiogenesis for intractable macroangiopathy-related digital ulcer in patients with systemic sclerosis: a pilot study.

Takagi G, Miyamoto M, Tara S, Kirinoki-Ichikawa S, Kubota Y, Hada T, Takagi I, Mizuno K.

Rheumatology (Oxford). 2014 May;53(5):854-9. doi: 10.1093/rheumatology/ket432. Epub 2014 Jan 3.

PMID:
24390937
37.

Comparison of the catalytic activities of three isozymes of carnitine palmitoyltransferase 1 expressed in COS7 cells.

Hada T, Yamamoto T, Yamamoto A, Ohkura K, Yamazaki N, Takiguchi Y, Shinohara Y.

Appl Biochem Biotechnol. 2014 Feb;172(3):1486-96. doi: 10.1007/s12010-013-0619-y. Epub 2013 Nov 13.

PMID:
24222496
38.

Physiological responses of young thoroughbred horses to intermittent high-intensity treadmill training.

Ohmura H, Matsui A, Hada T, Jones JH.

Acta Vet Scand. 2013 Aug 17;55:59. doi: 10.1186/1751-0147-55-59.

39.

Obstetric outcomes of patients undergoing total laparoscopic radical trachelectomy for early stage cervical cancer.

Ebisawa K, Takano M, Fukuda M, Fujiwara K, Hada T, Ota Y, Kurotsuchi S, Kanao H, Andou M.

Gynecol Oncol. 2013 Oct;131(1):83-6. doi: 10.1016/j.ygyno.2013.07.108. Epub 2013 Aug 1.

PMID:
23917083
40.

Oral administration of monogalactosyl diacylglycerol from spinach inhibits colon tumor growth in mice.

Maeda N, Kokai Y, Hada T, Yoshida H, Mizushina Y.

Exp Ther Med. 2013 Jan;5(1):17-22. Epub 2012 Nov 1.

41.

[Total laparoscopic radical hysterectomy--port reduction technique].

Andou M, Ebisawa K, Umemura K, Nagase T, Fujiwara K, Hada T, Ohta Y, Kanao H, Okumura M.

Nihon Rinsho. 2012 Jun;70 Suppl 4:217-31. Japanese. No abstract available.

PMID:
23156246
42.

In vivo antitumor effect of liposomes with sialyl Lewis X including monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach.

Mizushina Y, Hada T, Yoshida H.

Oncol Rep. 2012 Sep;28(3):821-8. doi: 10.3892/or.2012.1893. Epub 2012 Jul 3.

PMID:
22767329
43.

Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.

Mikami T, Hada T, Chosa N, Ishisaki A, Mizuki H, Takeda Y.

J Oral Pathol Med. 2013 Feb;42(2):133-9. doi: 10.1111/j.1600-0714.2012.01182.x. Epub 2012 Jun 5.

PMID:
22672247
44.

Total laparoscopic hysterectomy in 1253 patients using an early ureteral identification technique.

Kobayashi E, Nagase T, Fujiwara K, Hada T, Ota Y, Takaki Y, Kanao H, Andou M.

J Obstet Gynaecol Res. 2012 Sep;38(9):1194-200. doi: 10.1111/j.1447-0756.2012.01849.x. Epub 2012 Apr 30.

PMID:
22540927
45.

Comparison of two expression systems using COS7 cells and yeast cells for expression of heart/muscle-type carnitine palmitoyltransferase 1.

Hada T, Kato Y, Obana E, Yamamoto A, Yamazaki N, Hashimoto M, Yamamoto T, Shinohara Y.

Protein Expr Purif. 2012 Mar;82(1):192-6. doi: 10.1016/j.pep.2012.01.006. Epub 2012 Jan 14.

PMID:
22266133
46.

Properties of signal intensities observed with individual probes of GeneChip Rat Gene 1.0 ST Array, an affymetric microarray system.

Obana E, Hada T, Yamamoto T, Kakuhata R, Saze T, Miyoshi H, Hori T, Shinohara Y.

Biotechnol Lett. 2012 Feb;34(2):213-9. doi: 10.1007/s10529-011-0776-4. Epub 2011 Oct 19.

PMID:
22009574
47.

Multicenter, open-label study of long-term administration of febuxostat (TMX-67) in Japanese patients with hyperuricemia including gout.

Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S50-6. doi: 10.1097/RHU.0b013e31822541d0.

PMID:
21654270
48.

An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.

Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S44-9. doi: 10.1097/RHU.0b013e31821d352f. Erratum in: J Clin Rheumatol. 2014 Sep;20(6):E3. Naoyuki, Kamatani [Kamatani, Naoyuki]; Shin, Fujimori [corrected to Fujimori, Shin]; Toshikazu, Hada [corrected to Hada, Toshikazu]; Tatsuo, Hosoya [corrected to Hosoya, Tatsuo]; Kenjiro, Kohri [corrected to Kohri, Kenjiro]; Toshitaka, Nakamura [corrected.

PMID:
21654269
49.

Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.

Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S35-43. doi: 10.1097/RHU.0b013e31821d351d. Erratum in: J Clin Rheumatol. 2014 Sep;20(6):E2. Naoyuki, Kamatani [corrected to Kamatani, Naoyuki]; Shin, Fujimori [corrected to Fujimori, Shin]; Toshikazu, Hada [corrected to Hada, Toshikazu]; Tatsuo, Hosoya [corrected to Hosoya, Tatsuo]; Kenjiro, Kohri [corrected to Kohri, Kenjiro]; Toshitaka, Nakamur.

PMID:
21654268
50.

Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.

Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S19-26. doi: 10.1097/RHU.0b013e31821d36de. Erratum in: J Clin Rheumatol. 2014 Sep;20(6):E1. Naoyuki, Kamatani [corrected to Kamatani, Naoyuki]; Shin, Fujimori [corrected to Fujimori, Shin]; Toshikazu, Hada [corrected to Hada, Toshikazu]; Tatsuo, Hosoya [corrected to Hosoya, Tatsuo]; Kenjiro, Kohri [corrected to Kohri, Kenjiro]; Toshitaka, Nakamur.

PMID:
21654266

Supplemental Content

Support Center